Impact of diabetes mellitus on myocardial perfusion after primary angioplasty in patients with acute myocardial infarction
Abhiram Prasad, MD, MRCP, FACC*,
Gregg W. Stone, MD, FACC ,*,
Thomas D. Stuckey, MD, FACC ,
Costantino O. Costantini, MD ,
Peter J. Zimetbaum, MD, FACC ,
Michael McLaughlin, MD ,
Roxana Mehran, MD, FACC ,
Eulogio Garcia, MD||,
James E. Tcheng, MD, FACC¶,
David A. Cox, MD, FACC#,
Cindy L. Grines, MD, FACC**,
Alexandra J. Lansky, MD, FACC and
Bernard J. Gersh, MBChB, DPhil, FACC*
* Division of Cardiovascular Diseases and Department of Internal Medicine, Mayo Clinic and Mayo Foundation, Rochester, Minnesota
Columbia University Medical Center and the Cardiovascular Research Foundation, New York, New York
Moses Cone Heart and Vascular Center, Greensboro, North Carolina
Beth Israel Deaconess Medical Center, Boston, Massachusetts
|| Hospital Gregorio Maranon, Madrid, Spain
¶ Duke Clinical Research Institute, Durham, North Carolina
# Mid Carolina Cardiology, Charlotte, North Carolina
** William Beaumont Hospital, Royal Oak, Michigan

View larger version (19K):
[in a new window]
|
Figure 1 Myocardial perfusion grade after intervention in patients with and without diabetes.
|
|

View larger version (18K):
[in a new window]
|
Figure 2 ST-segment resolution after intervention in patients with and without diabetes.
|
|

View larger version (12K):
[in a new window]
|
Figure 3 Relationship between myocardial blush grade and 30-day (left) and 1-year (right) mortality in patients with (n = 232) and without diabetes (n = 1,069).
|
|

View larger version (16K):
[in a new window]
|
Figure 4 Relationship between the ST-segment resolution and 30-day (left) and 1-year (right) mortality in patients with (n = 118) and without diabetes (n = 582).
|
|
|